Skip to main contentSkip to navigation
Sirius Investors
Kelly CRISPR & Gene Editing Technology ETF

Kelly CRISPR & Gene Editing Technology ETF

XDNA
NASDAQFinancial Services

Kelly CRISPR & Gene Editing Technology ETF (XDNA) Investment Research Dashboard

About Kelly CRISPR & Gene Editing Technology ETF (XDNA) stock analysis

Get live XDNA stock price $7.38, comprehensive Kelly CRISPR & Gene Editing Technology ETF stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time XDNA stock data and investment insights.

7.38
1.60%Today
Market Cap
2.58M
Volume
4.25K
52W High
11.83
52W Low
5.87

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

The fund employs a passive investment strategy, aiming to replicate the total return performance of its benchmark index. This index is rule-based, comprising equities or their corresponding depositary receipts from companies involved in the entire sp...

Company Information

CEO
Sector
Financial Services
Industry
Asset Management
Employees
N/A

Contact Information

Website
Address
7887 East Belleview Avenue, Suite 1100
Country
CA

Investment Analysis & Business Insights

Financial Services
Asset Management

Investment Highlights

Strong presence in the Financial Services sector with established market position

Lower volatility stock (Beta: 0.00) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Kelly CRISPR & Gene Editing Technology ETF shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Financial Services may affect company performance
  • Past performance does not guarantee future results for Kelly CRISPR & Gene Editing Technology ETF
  • Investors should consider how Kelly CRISPR & Gene Editing Technology ETF fits within their overall portfolio allocation

Market Cap

2.58M

Beta

0.00

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Financial Services Sector

The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.

Financial Services (1D)

98/100 ⭐⭐⭐⭐⭐

Overall
-0.4%
NYSE
-0.4%
NASDAQ
-0.3%
Sector1D1W1MP/EScore
Financial Services-0.4%+3.0%+3.4%19.0
98/100⭐⭐⭐⭐⭐
Communication Services+0.4%+1.9%+3.3%22.3
86/100⭐⭐⭐⭐⭐
Consumer Defensive+0.5%+2.4%+2.0%29.9
72/100⭐⭐⭐⭐⭐
Healthcare-0.8%+1.8%+1.9%23.9
68/100⭐⭐⭐⭐
Basic Materials-1.1%-0.4%-1.8%24.9
58/100⭐⭐⭐⭐
Energy-0.4%-4.2%-3.5%19.4
47/100⭐⭐⭐
Real Estate-1.6%-1.2%-2.6%28.7
44/100⭐⭐⭐
Consumer Cyclical-0.3%-1.1%-7.0%41.9
33/100⭐⭐
Utilities-2.7%-4.7%-7.5%25.9
22/100
Industrials-2.6%-1.6%-14.0%29.0
14/100
Technology-2.5%-5.3%-12.4%39.8
8/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-30.